Search Within

Maria Eugenia Arcila

Formats
  1. Meeting Abstract (391)
  2. Journal Article (247)
  3. Research Letter (12)
  4. Book Section (8)
  5. Review (7)
  6. Editorial (2)
  7. Guidelines (2)
  8. Book Whole (1)
Groups
  1. Department of Pathology and Laboratory Medicine (670)
  2. Department of Medicine (458)
  3. GSK Faculty (456)
  4. Human Oncology and Pathogenesis Program (427)
  5. Tow Center for Developmental Oncology (TCDO) (346)
  6. Solid Tumor Oncology Division (317)

More Groups

People
  1. Marc Ladanyi (301)
  2. Michael Berger (163)
  3. Ahmet Zehir (126)
  4. Mark Kris (123)
  5. Khedoudja Nafa (108)
  6. Ryma Benayed (99)

More People

Years
  1. 2025 (11)
  2. 2024 (29)
  3. 2023 (43)
  4. 2022 (32)
  5. 2021 (37)
  6. 2020 (68)

More Years

Publications
  1. Journal of Molecular Diagnostics (93)
  2. Journal of Clinical Oncology (80)
  3. Laboratory Investigation (74)
  4. Modern Pathology (69)
  5. Blood (55)
  6. Clinical Cancer Research (36)

More Publications

Publishers
  1. Elsevier Science, Inc. (98)
  2. Nature Publishing Group (97)
  3. American Society of Clinical Oncology (96)
  4. Nature Research (69)
  5. American Association for Cancer Research (61)
  6. American Society of Hematology (61)

More Publishers

Results (670)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activation of KRAS mediates resistance to targeted therapy in MET exon 14–mutant non–small cell lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Lu, D.; Kurzatkowski, C.; Vojnic, M.; Smith, R. S.; Sabari, J. K.; Tai, H.; Mattar, M.; Khodos, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Genomic differences between “primary” and “secondary” muscle-invasive bladder cancer as a basis for disparate outcomes to cisplatin-based neoadjuvant chemotherapy
    Editorial

    Pietzak, E. J.; Zabor, E. C.; Bagrodia, A.; Armenia, J.; Hu, W.; Zehir, A.; Funt, S.; Audenet, F.; Barron, D.; Maamouri, N.; more...
    European Urology (2019)

    Fulltext@MSK | Save
  • Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: A retrospective international multicentre study
    Journal Article

    Lai, W. V.; Lebas, L.; Barnes, T. A.; Milia, J.; Ni, A.; Gautschi, O.; Peters, S.; Ferrara, R.; Plodkowski, A. J.; Kavanagh, J.; more...
    European Journal of Cancer (2019)

    Fulltext@MSK | Save
  • Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations
    Journal Article

    Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
    Urologic Oncology: Seminars and Original Investigations (2019)

    Fulltext@MSK | Save
  • Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)
    Meeting Abstract

    Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Acquired BRAF fusions as a mechanism of resistance to EGFR therapy
    Meeting Abstract

    Vojnic, M.; Kurzatkowski, C.; Kubota, D.; Suzawa, K.; Liu, Z.; Mattar, M.; Khodos, I.; Poirier, J. T.; de Stanchina, E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection
    Meeting Abstract

    Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict response to HER2-targeted therapy
    Meeting Abstract

    Liu, D.; Offin, M. D.; Olah, Z. T.; Tarcic, G.; Zelichov, O.; Vidne, M.; Drilon, A. E.; Arcila, M. E.; Li, B. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save